Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K. Cunningham, Karin Nielsen‐Saines, Jeffrey T. Safrit et al.|The Journal of Infectious Diseases|2019Cited by 62
Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus InfectionJennifer J. Kiser, Peter L. Havens, Courtney V. Fletcher et al.|Antimicrobial Agents and Chemotherapy|2007Cited by 58